BioConsortia has raised $15 million in its most recent funding round.

Share This Article

BioConsortia, Inc., a pioneering leader in microbial gene-editing for agricultural applications, has recently concluded a successful internal financing round aimed at propelling the development of cutting-edge microbial products. These innovative solutions, designed to enhance crop yields by addressing challenges such as nitrogen fixation, nematode and fungal control, and soil insect pest management, signify a significant stride towards sustainable and eco-friendly agricultural practices. Led by Otter Capital, a prominent investor impressed by BioConsortia’s substantial progress in field trials and groundbreaking discoveries, this financing round underlines the company’s commitment to revolutionizing agriculture through advanced microbial technologies.

Read The Full Article Below-